Unichem Laboratories informs about press release

19 Feb 2021 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Unichem Laboratories has informed that it has enclosed the press release on 19th February 2021 pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem’s Apremilast Tablets, 10 mg, 20 mg and 30 mg.

The above information is a part of company’s filings submitted to BSE.

Unichem Lab Share Price

724.50 -2.35 (-0.32%)
03-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.10
Dr. Reddys Lab 1352.75
Cipla 1510.25
Lupin 2367.85
Zydus Lifesciences 975.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.